Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior

PartnershipGABAB Positive Allosteric Modulator PortfolioPositive

AI Analysis

Summary

Addex has regained rights to its GABAB positive allosteric modulator portfolio from Indivior. The strategic move restores Addex's control over the therapeutic program.

Importance:5/10

Sentiment:

0.60

licensingportfolio acquisitionrights reacquisitionGABAdrug development

Related Companies

$ADXN $INDV.L

Read the original article

Published by yahoo_finance on September 25, 2026 5:00 AM

Read Original